Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    2,634

Stocks News & Analysis

stocks

Alphabet raises $80 billion for AI efforts

$10 billion private placement to Berkshire Hathaway as part of equity raise.
stocks

Undervalued ASX healthcare provider

Solid demand profile for global leader.
stocks

SpaceX: What investors need to know about its enormous upcoming IPO

Morningstar launches research coverage of SpaceX.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,017.203.10-0.03%
CAC 408,173.3035.79-0.44%
DAX 4024,927.26196.91-0.78%
Dow JONES (US)51,307.79228.910.45%
FTSE 10010,340.7332.78-0.32%
HKSE25,632.51405.81-1.56%
NASDAQ27,093.907.090.03%
Nikkei 22568,402.131,667.892.50%
NZX 50 Index13,115.0855.63-0.42%
S&P 5007,609.789.820.13%
S&P/ASX 2008,785.705.900.07%
SSE Composite Index4,083.978.870.22%

Market Movers